FI964605A0 - Hepatit-G virus och molekylkloning därav - Google Patents

Hepatit-G virus och molekylkloning därav

Info

Publication number
FI964605A0
FI964605A0 FI964605A FI964605A FI964605A0 FI 964605 A0 FI964605 A0 FI 964605A0 FI 964605 A FI964605 A FI 964605A FI 964605 A FI964605 A FI 964605A FI 964605 A0 FI964605 A0 FI 964605A0
Authority
FI
Finland
Prior art keywords
hgv
hepatitis
antigens
methods
virus
Prior art date
Application number
FI964605A
Other languages
English (en)
Finnish (fi)
Other versions
FI112249B (sv
FI964605A (sv
Inventor
Jungsuh P Kim
Kirk E Fry
Lavonne Marie Young
Jeffrey M Linnen
John Wages
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of FI964605A0 publication Critical patent/FI964605A0/sv
Publication of FI964605A publication Critical patent/FI964605A/sv
Application granted granted Critical
Publication of FI112249B publication Critical patent/FI112249B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
FI964605A 1994-05-20 1996-11-18 Hepatitis G virus och molekylkloning därav FI112249B (sv)

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US24698594A 1994-05-20 1994-05-20
US24698594 1994-05-20
US28555894A 1994-08-03 1994-08-03
US28554394A 1994-08-03 1994-08-03
US28554394 1994-08-03
US28555894 1994-08-03
US32972994A 1994-10-26 1994-10-26
US32972994 1994-10-26
US34427194A 1994-11-23 1994-11-23
US34427194 1994-11-23
US35750994A 1994-12-16 1994-12-16
US35750994 1994-12-16
US38988695A 1995-02-15 1995-02-15
US38988695 1995-02-15
US9506169 1995-05-19
PCT/US1995/006169 WO1995032291A2 (en) 1994-05-20 1995-05-19 Hepatitis g virus and molecular cloning thereof

Publications (3)

Publication Number Publication Date
FI964605A0 true FI964605A0 (sv) 1996-11-18
FI964605A FI964605A (sv) 1997-01-15
FI112249B FI112249B (sv) 2003-11-14

Family

ID=27569460

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964605A FI112249B (sv) 1994-05-20 1996-11-18 Hepatitis G virus och molekylkloning därav

Country Status (16)

Country Link
EP (1) EP0763114B1 (sv)
JP (2) JPH10503642A (sv)
KR (1) KR100394693B1 (sv)
CN (1) CN1125877C (sv)
AT (1) ATE210185T1 (sv)
CA (1) CA2190860A1 (sv)
DE (1) DE69524407T2 (sv)
DK (1) DK0763114T3 (sv)
ES (1) ES2170152T3 (sv)
FI (1) FI112249B (sv)
HK (1) HK1012412A1 (sv)
MX (1) MX9605666A (sv)
NO (1) NO323849B1 (sv)
NZ (1) NZ288000A (sv)
PT (1) PT763114E (sv)
WO (1) WO1995032291A2 (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051374A (en) * 1994-02-14 2000-04-18 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6720166B2 (en) 1994-02-14 2004-04-13 Abbott Laboratories Non-a, non-b, non-c, non-c, non-d, non-e hepatitis reagents and methods for their use
US6451578B1 (en) 1994-02-14 2002-09-17 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6558898B1 (en) 1994-02-14 2003-05-06 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US6156495A (en) * 1994-02-14 2000-12-05 Abbott Laboratories Hepatitis GB virus recombinant proteins and uses thereof
US6586568B1 (en) 1994-02-14 2003-07-01 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
US5843450A (en) * 1994-02-14 1998-12-01 Abbott Laboratories Hepatitis GB Virus synthetic peptides and uses thereof
US5981172A (en) * 1994-02-14 1999-11-09 Abbott Laboratories Non-A, non-B, non-C, non-D, non-E Hepatitis reagents and methods for their use
US5807670A (en) * 1995-08-14 1998-09-15 Abbott Laboratories Detection of hepatitis GB virus genotypes
US5955318A (en) * 1995-08-14 1999-09-21 Abbott Laboratories Reagents and methods useful for controlling the translation of hepatitis GBV proteins
US5709997A (en) * 1995-08-14 1998-01-20 Abbott Laboratories Nucleic acid detection of hepatitis GB virus
WO1997019195A1 (de) * 1995-11-21 1997-05-29 Boehringer Mannheim Gmbh Amplifikation von nukleinsäuren und nachweis eines neuen hepatitis-nona/nonb/nonc/nond/none-virus
IT1283893B1 (it) * 1996-01-24 1998-05-07 Sorin Biomedica Diagnostics Sp Metodo per rilevare sequenze nucleotidiche di virus associati a epatiti nona-none, peptidi e composizioni
DE19613406A1 (de) * 1996-04-03 1997-10-09 Boehringer Mannheim Gmbh Expression von HGV-Antigenen und deren Verwendung
IT1284630B1 (it) * 1996-04-17 1998-05-21 Sorin Biomedica Diagnostics Sp Epitopi specifici di virus associati a epatiti non"a"-non"e", composizioni e metodo per rivelare anticorpi di detti epitopi.
US5766916A (en) * 1996-04-24 1998-06-16 Genelabs Technologies, Inc. Hepatitis G virus protease
US6020195A (en) * 1996-09-18 2000-02-01 Roche Diagnostics Gmbh Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent
AU752131C (en) * 1997-11-06 2003-12-04 Innogenetics N.V. Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
GB0009756D0 (en) * 2000-04-19 2000-06-07 Glaxo Group Ltd Test method
WO2014097762A1 (ja) * 2012-12-20 2014-06-26 国立大学法人熊本大学 高病原性トリインフルエンザに対する抗体
US9594163B2 (en) 2013-04-15 2017-03-14 Electronics And Telecommunications Research Institute Security and surveillance system and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4046489A (en) * 1988-07-06 1990-02-05 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
WO1994018217A1 (en) * 1993-02-03 1994-08-18 Abbott Laboratories Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
WO1995021922A2 (en) * 1994-02-14 1995-08-17 Abbott Laboratories Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use

Also Published As

Publication number Publication date
KR100394693B1 (ko) 2003-12-31
NZ288000A (en) 1998-09-24
NO964721D0 (no) 1996-11-07
AU684177B2 (en) 1997-12-04
CA2190860A1 (en) 1995-11-30
PT763114E (pt) 2002-05-31
KR970703425A (ko) 1997-07-03
CN1125877C (zh) 2003-10-29
ATE210185T1 (de) 2001-12-15
NO964721L (no) 1997-01-17
HK1012412A1 (en) 1999-07-30
JP4296174B2 (ja) 2009-07-15
AU2689595A (en) 1995-12-18
ES2170152T3 (es) 2002-08-01
MX9605666A (es) 1998-05-31
JPH10503642A (ja) 1998-04-07
FI112249B (sv) 2003-11-14
DE69524407D1 (de) 2002-01-17
NO323849B1 (no) 2007-07-09
DK0763114T3 (da) 2002-04-02
CN1153529A (zh) 1997-07-02
EP0763114A2 (en) 1997-03-19
DE69524407T2 (de) 2002-08-01
WO1995032291A2 (en) 1995-11-30
FI964605A (sv) 1997-01-15
EP0763114B1 (en) 2001-12-05
JP2006115845A (ja) 2006-05-11
WO1995032291A3 (en) 1996-03-07

Similar Documents

Publication Publication Date Title
FI964605A0 (sv) Hepatit-G virus och molekylkloning därav
ATE194844T1 (de) Hepatitis c-virus-epitope
DK480889A (da) Non-a, non-b, hepatitisvirus-antigenpeptid, cdna kodende derfor, fremgangsmaade til detektering deraf og bakteriestamme indeholdende et saadant cdna
KR960703136A (ko) 탠덤 합성 hiv-1 펩티드들
DE69131149D1 (de) Synthetische Peptide, spezifisch zum Nachweis von gegen HCV gerichteten Antikörpern zur Diagnose der HCV-Infektion und zum Vorkommen davon als Impfstoffe
DK0942983T3 (da) Streptococcus pneumoniae-antigener og -vacciner
DK0522030T3 (da) Hepatitis B-vaccine
KR940703851A (ko) E형 간염 바이러스 펩타이드 항원 및 항체(hepatitis e virus peptide antigens and antibodies)
CA2057052A1 (en) Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
WO1995032290A3 (en) Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
CA2075366A1 (en) Immunologically active peptides or polypeptides from the parvovirus b19
DE69106141T2 (de) Non-a non-b sequenzen.
PT97428A (pt) Processo para a preparacao de epitopos do virus da hepatite c
Bopp et al. Comparative studies on novel protein antigens of streptococci of the serological group B
KR930000127A (ko) 비(非)a 비(非)b형 간염 진단방법 및 백신
IT1241581B (it) Peptidi sintetici contenenti sequenze di aminoacidi che definiscono epitopi immunoreattivi contro anticorpi umani anti hcv, utili per l'allestimento di dosaggi immunologici.